Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jiuwei Zhenxin Granules plus trazodone for adolescent mixed anxiety and depression
ChiCTR2200067034Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Xinxiang Medical University
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of jiuwei zhenxin and trazodone in mixed anxiety-depressive disorder (2 arms), sponsored by The Second Affiliated Hospital of Xinxiang Medical University. Primary endpoints: Hamilton Anxiety Scale total score, Hamilton Anxiety Scale factor scores and 1 more. Started Mar 2021; status: recruiting.
02
Drugs
jiuwei zhenxintrazodone
03
Conditions
mixed anxiety-depressive disorder
Beyond the preview
Go deeper on ChiCTR2200067034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200067034.